![](https://investorshub.advfn.com/uicon/33199.png?cb=1474042454)
Tuesday, May 06, 2014 12:35:56 PM
Zoetis Announces Research Partnership with Iowa State University to Help Control Porcine Epidemic Diarrhea Virus in the United States
Collaboration focuses on developing and testing vaccine candidate for swine
Category:
Corporate (Partnerships), Farm Animals (Pigs), Products & Services (Vaccines)
Monday, February 10, 2014 5:41 pm EST
FLORHAM PARK, N.J., Feb. 10, 2014 — Zoetis Inc. today announced a research partnership with Iowa State University (ISU) to identify and test a vaccine candidate to help control porcine epidemic diarrhea virus (PEDv) in the United States.
“Establishing this partnership further affirms our commitment to fighting this devastating virus,” said Gloria Basse, vice president, U.S. Pork Business Unit, Zoetis. “We look forward to working with the top researchers at Iowa State University to share knowledge and expertise as we make every effort, together, to help veterinarians and producers fight PEDv.”
New cases of PEDv continue to mount. Since the beginning of December, more than 100 new cases have been reported each week.1 PEDv now has spread to swine farms in 23 states since April 2013, with documented farm cases in the thousands. Losses from PEDv are significant and have been measured on some farms at 100% mortality for infected piglets up to 3 weeks old.
“We know how devastating this virus has been to the swine industry,” said Jianqiang Zhang, MD, PhD, assistant professor, ISU Veterinary Diagnostic Laboratory. “We are eager to work with Zoetis and advance the research we’ve begun to find a solution.”
The development of a vaccine candidate is one element of Zoetis’ ongoing efforts to support swine veterinarians and pork producers control PEDv. In 2013, Zoetis began a collaboration with the University of Minnesota to develop a diagnostic test for the disease.
http://news.zoetis.com/press-release/iowa-state-university/zoetis-announces-research-partnership-iowa-state-university-help
NanoViricides (NNVC) should give Zoetis a call.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM